Press Release Source: Arizona Heart Innovative Technologies, LLC
Wednesday November 12, 8:45 am ET
PHOENIX, Nov. 12 -- Arizona Heart Innovative Technologies, LLC (AHIT) announced the license of a new medical device for endovascular use to a publicly traded medical device company. "This is the second AHIT-developed product that we have licensed in the past ten months. We continue to demonstrate our ability to bridge the gap between good ideas from the medical community to commercially viable products for medical device companies. This confirms the viability of our business model to serve as a cost-effective supplementary research and development resource for companies," says AHIT President and CEO, Bill Colone. "We have additional products that have completed the development process and we are continuing to discuss options with many device companies."
AHIT licensed the endovascular product in July of 2007 from Hani Shennib, MD, a cardiovascular surgeon formerly at the Arizona Heart Hospital. The product was prototyped, tested and marketed to multiple medical companies immediately following positive clinical test results. The product should reach both the U.S. and international markets by the first quarter of 2009.
About Arizona Heart Innovative Technologies, LLC
Bill Colone, who co-founded AHIT in August 2006, has over 26 years of experience in developing and marketing medical devices. He served as President of Endomed, Inc. for over ten years, until its sale to LeMaitre Vascular (LMAT) in February 2005. Bill holds eleven US patents for medical devices with other applications pending.
AHIT provides a vehicle for evaluating and commercializing ideas from the medical community. This process includes product due diligence, market research, securing intellectual property rights, prototyping, and matching the product to the best medical device company through a sales process. The company's Scientific Advisory Board (SAB) consists of cardiovascular surgeons and endovascular specialists with over 80 years of experience treating vascular disease. The SAB is chaired by Edward B. Diethrich, MD, the Medical Director and Founder of the Arizona Heart Institute and Arizona Heart Hospital. AHIT is supported by a Governing Board which includes many prominent business professionals with expertise in patent law, financial services, corporate management, and medical device marketing.
If you would like to discuss your idea or concept, please contact us:
Arizona Heart Innovative Technologies, LLC
10429 South 51st Street, Suite 220, Phoenix, AZ 85044
Tel: 602.200.0898 Fax: 602.200.0899
Email: bcolone@ahitechnologies.com
Web: http://www.ahitechnologies.com
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
Source: Arizona Heart Innovative Technologies, LLC